User profiles for Yingchi Yang

yingchi yang

Beijing Friendship Hospital; Capital Medical University
Verified email at ccmu.edu.cn
Cited by 495

UBR5 contributes to colorectal cancer progression by destabilizing the tumor suppressor ECRG4

J Wang, X Zhao, L Jin, G Wu, Y Yang - Digestive diseases and sciences, 2017 - Springer
Background The E3 ligase UBR5 is aberrantly expressed in diverse types of cancer. However,
its expression pattern and biological function in colorectal cancer (CRC) remain unclear. …

[HTML][HTML] Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer

D Wang, Y Yang, L Jin, J Wang, X Zhao, G Wu… - Journal of …, 2019 - ncbi.nlm.nih.gov
Background: It is urgent to develop robust prognostic biomarkers for non-metastatic colorectal
cancer (CRC) patients undergoing surgery. The current study aimed to explore and …

[HTML][HTML] The MiR-495/Annexin A3/P53 axis inhibits the invasion and EMT of colorectal cancer cells

…, J Wang, T Wang, Y Li, X Zhao, G Wu, Y Yang… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: More and more reports have shown that the dysregulation of miRNAs can
contribute to the progression and metastasis of human cancers. Many studies have shown …

Inhibition of neuroactive ligand–receptor interaction pathway can enhance immunotherapy response in colon cancer: an in silico study

Y Yang, J Li, C Jing, Y Zhai, Z Bai, Y Yang… - Expert Review of …, 2023 - Taylor & Francis
Background The potential mechanism underlying the association between Homologous
recombination deficiency (HRD) and immunotherapy in colon cancer has not been investigated. …

Electroacupuncture vs sham electroacupuncture in the treatment of postoperative ileus after laparoscopic surgery for colorectal cancer: a multicenter, randomized …

…, ZK Li, H Zhou, NN Yang, LQ Wang, YC Yang… - JAMA …, 2023 - jamanetwork.com
Importance Despite the adoption of the optimized Enhanced Recovery After Surgery (ERAS)
protocol, postoperative ileus (POI) severely impairs recovery after colorectal resection and …

[HTML][HTML] Sarcobesity, but not visceral fat, is an independent risk factor for complications after radical resection of colorectal cancer

…, K Pang, M Tian, X Gu, H Lin, X Yang, Y Yang… - Frontiers in …, 2023 - frontiersin.org
Background The influence of body composition on the outcome of colorectal cancer surgery
is controversial. The aim of this study was to evaluate the effects of visceral obesity and …

Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer

Y Yang, D Wang, L Jin, G Wu, Z Bai… - Cancer management …, 2018 - Taylor & Francis
Purpose The aim of this study was to investigate the prognostic value of the combination of
microsatellite instability (MSI) and BRAF V600E mutation in colorectal cancer (CRC). …

[HTML][HTML] BRCA genes as candidates for colorectal cancer genetic testing panel: systematic review and meta-analysis

…, W Deng, Y Zhao, J Guo, Y Yang, Z Zhang, Y Yang - BMC cancer, 2023 - Springer
Background Breast cancer susceptibility gene (BRCA) mutation carriers are at an increased
risk for breast, ovarian, prostate and pancreatic cancers. However, the role of BRCA is …

Associations of postoperative complications assessed by clavien–dindo classification and comprehensive complication index with long-term overall survival in elderly …

D Wang, J Zhang, Z Bai, Y Yang, T Wang… - … interventions in aging, 2020 - Taylor & Francis
Yingchi Yang1 Department of General Surgery, Beijing Friendship Hospital, Capital Medical
… study are available from the corresponding author, Yingchi Yang, upon reasonable request. …

Circulating tumor DNA detectable in early-and late-stage colorectal cancer patients

YC Yang, D Wang, L Jin, HW Yao, JH Zhang… - Bioscience …, 2018 - portlandpress.com
Characterization, diagnosis, and treatment of colorectal cancers (CRC) is difficult due to
limited biopsy information, impracticality of repeated biopsies, and cancer biomarker fallibility. …